1924P Efficacy and safety of lenvatinib in patients with chemotherapy-naive advanced or recurrent thymic carcinoma: A multicenter retrospective study
Hazama, D., Takagi, K., Saito, G., Tsugitomi, R., Ashinuma, H., Shukuya, T., Gyotoku, H., Sakata, S., Mouri, A., Miwa, H., Tamura, Y., Tokito, T., Tsukita, Y., Kogure, Y., Masuda, T., Tanaka, H., Kubo, S., Suzuki, T.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
316P Phase II study of ramucirumab and docetaxel for platinum-resistance NSCLC patients with malignant pleural effusion: Analysis of pleural effusion control rate
Ogata, R., Takemoto, S., Fukuda, M., Senju, H., Nakatomi, K., Sugasaki, N., Tomono, H., Suyama, T., Shimada, M., Akagi, K., Hayashi, F., Dotsu, Y., Taniguchi, H., Gyotoku, H., Yamaguchi, H., Nagashima, S., Soda, H., Kinoshita, A., Mukae, H.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
1015P Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1 negative or weakly positive advanced non-small cell lung cancer after disease progression on platinum-based therapy: WJOG10317L study (EMERALD)
Zenke, Y., Niho, S., Nakamura, A., Okamoto, T., Hara, S., Akazawa, Y., Hosomi, Y., Hayashi, H., Teraoka, S., Yokoyama, T., Ozaki, T., Ueno, K., Gyotoku, H., Misumi, T., Nakagawa, K., Yamamoto, N., Tsuboi, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
EP08.04-005 Phase II Study of Ramucirumab and Docetaxel for NSCLC Patients with Malignant Pleural Effusion
Takemoto, S., Fukuda, M., Senju, H., Nakatomi, K., Sugasaki, N., Ogata, R., Tomono, H., Suyama, T., Shimada, M., Akagi, K., Hayashi, F., Gyotoku, H., Yamaguchi, H., Nagashima, S., Soda, H., Kinoshita, A., Mukae, H.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
A retrospective analysis of patients with non-small cell lung cancer who developed drug-induced lung disorder by immune checkpoint inhibitors
Hayashi, F., Taniguchi, H., Takayuki, S., Umeyama, Y., Dotsu, Y., Gyotoku, H., Senju, H., Takemoto, S., Yamaguchi, H., Ono, S., Tomono, H., Shimada, M., Soda, H., Fukuda, M., Hiroshi, M.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
A retrospective analysis of immune checkpoint therapy in patients with non-small cell lung cancer: Focus on thyroid disorder
Ono, S., Senju, H., Taniguchi, H., Tomono, H., Shimada, M., Hayashi, F., Suyama, T., Honda, N., Umeyama, Y., Dotsu, Y., Gyotoku, H., Takemoto, S., Yamaguchi, H., Fukuda, M., Soda, H., Mukae, H.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
P1.03-015 The Relationship between the UGT1A127 and UGT1A17 Genetic Polymorphisms and Irinotecan-Related Toxicities in Patients with Lung Cancer
Fukuda, M., Okumura, M., Arimori, K., Takahira, A., Mori, M., Nakamura, D., Shimada, M., Taniguchi, H., Gyotoku, H., Senju, H., Ikeda, T., Yamaguchi, H., Nakatomi, K., Tsuchiya, T., Mukae, H., Ashizawa, K.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
Treatment of decubitus ulcer
Onizuka, T, Jinnouchi, T, Haraguchi, W, Tanaka, R, Udagawa, K, Gyotoku, H
Published in Nippon Seikeigekagakkai zasshi (01.08.1986)
Get more information
Published in Nippon Seikeigekagakkai zasshi (01.08.1986)
Journal Article